α2-adrenoceptor agonists as nasal decongestants

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 2, 2007, Pages 149-156

  Corboz, M R ^a   Mutter, J C ^a   Rivelli, M A ^a   Mingo, G G ^a   McLeod, R L ^a   Varty, L ^a   Jia, Y ^a   Cartwright, M ^a   Hey, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

2 Adrenoceptor agonist; BHT 920; Decongestion; Nasal mucosa

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA2 ADRENORECEPTOR AGONIST; DECONGESTIVE AGENT; PGE 6201204; PRAZOSIN; TALIPEXOLE; UNCLASSIFIED DRUG; YOHIMBINE; 4 METHOXY N METHYLPHENETHYLAMINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; AZEPINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CAPACITANCE BLOOD VESSEL; CAT; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; IN VIVO STUDY; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MALE; MONKEY; MUSCLE CONTRACTILITY; NONHUMAN; NOSE CONGESTION; NOSE MUCOSA; PRIORITY JOURNAL; SINUS VENOSUS; SWINE; VASOCONSTRICTION; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; IN VITRO STUDY; MACACA; MINIPIG; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AZEPINES; CATS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; FEMALE; MACACA FASCICULARIS; MACACA MULATTA; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NASAL DECONGESTANTS; NASAL MUCOSA; P-METHOXY-N-METHYLPHENETHYLAMINE; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE; SWINE, MINIATURE; VASOCONSTRICTION; YOHIMBINE;

EID: 33751179225     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.03.012     Document Type: Article

References (25)

1. O'Donnell S.R. Sympathomimetic vasoconstrictors as nasal decongestants. Med J Aust 162 (1995) 264-267
2. Drettner B., and Aust R. Plethysmographic studies of the blood flow in the mucosa of the human maxillary sinus. Acta Otolaryngol 74 (1974) 259-263
3. Druce H.M., Bonner R.F., Patow C., Choo P., and Kaliner M.A. Response of nasal blood flow to neurohormones as measured by laser-Doppler velocimetry. J Appl Physiol 57 (1984) 1276-1283
4. White M.V., and Kaliner M.A. Mediators of allergic rhinitis. J Allergy Clin Immunol 90 (1992) 699-704
5. Widdicombe J. Microvascular anatomy of the nose. Allergy 52 (1997) 7-11
6. Lacroix J.S. Adrenergic and non-adrenergic mechanisms in the sympathetic vascular control of the nasal mucosa. Acta Physiol Scand 136 (1989) 1-63
7. Kristiansen A.B., Heyeraas K.J., and Kirkebo A. Increased pressure in venous sinusoids during decongestion of rat nasal mucosa induced by adrenergic agonists. Acta Physiol Scand 147 (1993) 151-161
8. Andersson K.-E., and Bende M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Rhino Laryngol 93 (1984) 179-182
9. Berridge T.L., and Roach A.G. Characterization of the α-adrenoceptors in the vasculature of the canine nasal mucosa. Br J Pharmacol 88 (1986) 345-354
10. 2-adrenoceptor-mediated responses in pig nasal mucosa. Aut Autac Pharmacol 23 (2004) 208-219
11. Corboz M.R., Rivelli M.A., Varty L.M., Mutter J., Cartwright M., Rizzo C.A., et al. Pharmacological characterization of postjunctional α-adrenoceptor in human nasal mucosa. Am J Rhinol 19 (2005) 495-502
12. Wang M., and Lung M.A. Adrenergic mechanisms in canine nasal venous systems. Br J Pharmacol 138 (2003) 145-155
13. 2-adrenergic receptor subtypes in nasal epithelium, gland and vascular cells. Anesthesiology 87 (1997) A1078
14. Van Megen Y.J.B., Klaassen A.B.M., Rodrigues de Miranda J.F., van Ginneken C.A.M., and Wentges B.T.R. Alterations of adrenoceptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals. J Allergy Clin Immunol 87 (1991) 530-540
15. Berkowitz R.B., McCafferty F., and Dato M.E. A proof of concept trial demonstrating decongestant activity of an apha2 adrenergic receptor agonist in patients with seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 115 (2005) S127
16. Tallarida R.J. I: Pharmacologic methods for identification of receptors. Life Sci 43 (1988) 2169-2176
17. McLeod R.L., Mingo G.G., Herczku C., Corboz M.R., Ramos S.I., DeGennaro-Culver F., et al. Changes in nasal resistance and nasal geometry using pressure and acoustic rhinometry in a feline model of nasal congestion. Am J Rhinol 13 (1999) 375-383
18. 2-adrenoceptor agonist BHT-920 produces decongestion in the cat. Am J Rhinol 15 (2001) 407-415
19. 2-adrenoceptor agonist in nasal mucosa. Arch Physiol Biochem 11 (2003) 335-336
20. 2 adrenergic agonist. FASEB J 10 (1996) A426
21. Macia R.A., Matthews W.D., Lafferty J., and Demarinis R.M. Assessment of alpha-adrenergic receptor subtypes in isolated rat aortic segments. Naunyn-Schmiedeberg's Arch Pharmacol 325 (1984) 306-309
22. 2c-adrenoceptor contractility in human saphenous vein. Eur J Pharmacol 413 (2001) 263-269
23. Steen S., Sjöberg T., Skärby T., Norgren L., and Andersson K.-E. The postjunctional α-adrenoceptors of the human saphenous vein. Acta Pharmacol Toxicol 55 (1984) 351-357
24. Weinstein J.S., Grossman W., Weintraub R.M., Thurer R.L., Johnson R.G., and Morgan K.G. Differences in α-adrenergic responsiveness between human internal mammary arteries and saphenous veins. Circulation 79 (1989) 1264-1270
25. Berger G., Balum-Azim M., and Ophir D. The normal inferior turbinate: histomorphometric analysis and clinical implications. Laryngoscope 113 (2003) 1292-1298